Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0C6ID
|
||||
Former ID |
DIB015851
|
||||
Drug Name |
Citatuzumab bogatox
|
||||
Synonyms |
VB6-845; Antibody therapeutic (ovary tumor), Viventia; Ovary cancer therapeutic (antibody), Viventia; Anti-EpCAM-bouganin conjugate (anticancer), Viventia
|
||||
Drug Type |
Antibody
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Phase 1 | [522038] | ||
Company |
Viventia Biotech Inc
|
||||
CAS Number |
CAS 945228-49-9
|
||||
Target and Pathway | |||||
Target(s) | Tumor-associated calcium signal transducer 1 | Target Info | [531988] | ||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.